DPP-4活性与骨密度、身体成分及髋部骨折发生的关系:心血管健康研究
在心血管健康研究(CHS)的1536名老年社区居住者中,血浆DPP-4活性水平与骨密度、身体成分及髋部骨折发生均无显著关联;DPP-4活性在黑人中显著高于白人(227 ± 78 vs 216 ± 89,p = 0.04),但与年龄或性别无关。
要点
- 在老年社区居住人群中,血浆DPP-4活性与骨密度、身体成分及髋部骨折发生无显著关联。
- 血浆DPP-4活性在黑人中显著高于白人(227 ± 78 vs 216 ± 89,p = 0.04)。
- DPP-4活性与年龄或性别无显著关联(两者p ≥ 0.14)。
核心结论
- 在内源性生理范围内,血浆DPP-4活性与种族显著相关,但与骨密度、身体成分或髋部骨折发生无显著关联。
研究设计与样本
- 研究纳入心血管健康研究(CHS)中所有具有可评估DXA扫描和血浆DPP-4活性检测的1536名男性和女性参与者。
主要发现
- 血浆DPP-4活性均值在黑人中为227 ± 78,显著高于白人的216 ± 89(p = 0.04)。
- 在多变量校正模型中,血浆DPP-4活性与总体骨密度无显著关联(所有p ≥ 0.55),在性别分层分析中亦无显著关联(p ≥ 0.23)。
- DPP-4水平与髋部骨折发生总体无显著关联(p ≥ 0.24),在性别分层分析中亦无显著关联(p ≥ 0.39)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: There was no association of plasma DPP-4 activity levels with bone mineral density (BMD), body composition, or incident hip fractures in a cohort of elderly community-dwelling adults. INTRODUCTION: Dipeptidyl peptidase IV (DPP-4) inactivates several key hormones including those that stimulate postprandial insulin secretion, and DPP-4 inhibitors (gliptins) are approved to treat diabetes. While DPP-4 is known to modulate osteogenesis, the relationship between DPP-4 activity and skeletal health is uncertain. The purpose of the present study was to examine possible associations between DPP-4 activity in elderly subjects enrolled in the Cardiovascular Health Study (CHS) and BMD, body composition measurements, and incident hip fractures. METHODS: All 1536 male and female CHS participants who had evaluable DXA scans and plasma for DPP-4 activity were included in the analyses. The association between (1) BMD of the total hip, femoral neck, lumbar spine, and total body; (2) body composition measurements (% lean, % fat, and total body mass); and (3) incident hip fractures and plasma levels of DPP-4 activity were determined. RESULTS: Mean plasma levels of DPP-4 activity were significantly higher in blacks (227 ± 78) compared with whites (216 ± 89) (p = 0.04). However, there was no significant association of DPP-4 activity with age or gender (p ≥ 0.14 for both). In multivariable adjusted models, there was no association of plasma DPP-4 activity with BMD overall (p ≥ 0.55 for all) or in gender stratified analyses (p ≥ 0.23). There was also no association of DPP-4 levels and incident hip fractures overall (p ≥ 0.24) or in gender stratified analyses (p ≥ 0.39). CONCLUSION: Plasma DPP-4 activity, within the endogenous physiological range, was significantly associated with race, but not with BMD, body composition, or incident hip fractures in elderly community-dwelling subjects.
引用
- Carbone LD, Bůžková P, Fink HA, et al. Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study. Osteoporos Int. 2017. PMID: 28150034. doi:10.1007/s00198-017-3916-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。